A Wenz

410 total citations
10 papers, 360 citations indexed

About

A Wenz is a scholar working on Physiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Wenz has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Wenz's work include Diabetes Treatment and Management (3 papers), Influenza Virus Research Studies (2 papers) and Pneumonia and Respiratory Infections (2 papers). A Wenz is often cited by papers focused on Diabetes Treatment and Management (3 papers), Influenza Virus Research Studies (2 papers) and Pneumonia and Respiratory Infections (2 papers). A Wenz collaborates with scholars based in Germany, United States and United Kingdom. A Wenz's co-authors include Colin Thorpe, Sandro Ghisla, Hubert Kolb, Kerstin Bellmann, Rainer Kleemann, J Radons, Volker Burkart, Tino F. Schwarz, Beate Schmöele-Thoma and C. Juergens and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

A Wenz

9 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Wenz Germany 7 120 98 55 50 49 10 360
Zhao Gao China 12 166 1.4× 99 1.0× 49 0.9× 27 0.5× 37 0.8× 24 463
Serena Longo Italy 11 149 1.2× 65 0.7× 71 1.3× 26 0.5× 18 0.4× 17 361
Igor Aurrekoetxea Spain 11 155 1.3× 150 1.5× 48 0.9× 37 0.7× 25 0.5× 17 406
Huiwen Xu China 9 213 1.8× 56 0.6× 78 1.4× 18 0.4× 52 1.1× 13 388
S. Venkatesan United Kingdom 11 207 1.7× 53 0.5× 45 0.8× 22 0.4× 173 3.5× 25 537
Wheeler Torres Venezuela 9 104 0.9× 25 0.3× 59 1.1× 26 0.5× 29 0.6× 23 331
Lyn M. Hillyer Canada 14 129 1.1× 114 1.2× 99 1.8× 15 0.3× 20 0.4× 36 507
Toru Mochizuki Japan 12 298 2.5× 84 0.9× 111 2.0× 17 0.3× 86 1.8× 31 541
Magdalena P. Cardelo Spain 12 97 0.8× 42 0.4× 110 2.0× 61 1.2× 37 0.8× 23 371
Katharina Herzog Sweden 12 217 1.8× 70 0.7× 68 1.2× 33 0.7× 53 1.1× 18 411

Countries citing papers authored by A Wenz

Since Specialization
Citations

This map shows the geographic impact of A Wenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Wenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Wenz more than expected).

Fields of papers citing papers by A Wenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Wenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Wenz. The network helps show where A Wenz may publish in the future.

Co-authorship network of co-authors of A Wenz

This figure shows the co-authorship network connecting the top 25 collaborators of A Wenz. A scholar is included among the top collaborators of A Wenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Wenz. A Wenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bornstein, Stefan R., Dick de Zeeuw, Hiddo J.L. Heerspink, et al.. (2024). Aldosterone synthase inhibitor ( BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial. Diabetes Obesity and Metabolism. 26(6). 2128–2138. 21 indexed citations
2.
Cherney, David Z.I., Dick de Zeeuw, Hiddo J.L. Heerspink, et al.. (2023). Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial. Diabetes Obesity and Metabolism. 25(8). 2218–2226. 10 indexed citations
3.
Cherney, David Z.I., Dick de Zeeuw, Hiddo J.L. Heerspink, et al.. (2021). Phase Ib Study of the Soluble Guanylate Cyclase Activator BI 685509 in Patients with Diabetic Kidney Disease. Journal of the American Society of Nephrology. 32(10S). 264–264. 1 indexed citations
6.
Palmer, Daniel H., Yuk Ting, Markus Peck‐Radosavljevic, et al.. (2015). Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 33(3_suppl). 238–238. 13 indexed citations
8.
Schwarz, Tino F., H. C. Rümke, C. Juergens, et al.. (2009). Safety and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Given Concomitantly with Trivalent Inactivated Influenza Vaccine in Healthy Adults. Journal of the American Geriatrics Society. 57.
9.
Bellmann, Kerstin, A Wenz, J Radons, et al.. (1995). Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro.. Journal of Clinical Investigation. 95(6). 2840–2845. 134 indexed citations
10.
Wenz, A, Colin Thorpe, & Sandro Ghisla. (1981). Inactivation of general acyl-CoA dehydrogenase from pig kidney by a metabolite of hypoglycin A.. Journal of Biological Chemistry. 256(19). 9809–9812. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026